SMTI Financial Statements

Balance sheet, income statement, cash flow, and dividends for Sanara Medtech Inc (SMTI).


$290.21M Market Cap.

As of 03/25/2025 5:00 PM ET (MRY) • Disclaimer

SMTI Market Cap. (MRY)


SMTI Shares Outstanding (MRY)


SMTI Assets (MRY)


Total Assets

$88.09M

Total Liabilities

$49.18M

Total Investments

$9.40M

SMTI Income (MRY)


Revenue

$86.67M

Net Income

-$9.66M

Operating Expense

$87.19M

SMTI Cash Flow (MRY)


CF Operations

-$23.78K

CF Investing

-$6.61M

CF Financing

$17.37M

SMTI Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

SMTI Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$88,091,992 (19.25%)

$73,871,149 (21.03%)

$61,035,386 (67.70%)

$36,396,431 (270.40%)

Assets Current

$33,305,988 (75.24%)

$19,005,869 (-7.81%)

$20,616,509 (-16.22%)

$24,608,495 (449.01%)

Assets Non-Current

$54,786,004 (-0.14%)

$54,865,280 (35.74%)

$40,418,877 (242.88%)

$11,787,936 (120.59%)

Goodwill & Intangible Assets

$44,608,557 (-8.08%)

$48,527,842 (38.21%)

$35,111,761 (642.64%)

$4,727,970 (52.63%)

Shareholders Equity

$39,403,573 (-12.11%)

$44,832,277 (7.18%)

$41,827,530 (36.51%)

$30,640,401 (398.17%)

Property Plant & Equipment Net

$1,880,224 (-42.20%)

$3,253,160 (46.35%)

$2,222,838 (8.82%)

$2,042,615 (78.20%)

Cash & Equivalents

$15,878,295 (208.48%)

$5,147,216 (-42.55%)

$8,958,995 (-51.97%)

$18,652,841 (3996.23%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$9,398,701 (204.73%)

$3,084,278 (0.00%)

$3,084,278 (-38.53%)

$5,017,351 (356.12%)

Investments Current

$1,101,478 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$8,297,223 (169.02%)

$3,084,278 (0.00%)

$3,084,278 (-38.53%)

$5,017,351 (356.12%)

Inventory

$2,753,032 (-41.64%)

$4,717,533 (32.93%)

$3,549,000 (73.27%)

$2,048,191 (78.37%)

Trade & Non-Trade Receivables

$12,449,385 (45.90%)

$8,532,709 (21.83%)

$7,003,903 (134.23%)

$2,990,145 (31.91%)

Trade & Non-Trade Payables

$1,530,677 (-23.54%)

$2,001,887 (40.31%)

$1,426,737 (140.20%)

$593,971 (20.03%)

Accumulated Retained Earnings (Deficit)

-$37,784,392 (-34.77%)

-$28,036,814 (-19.84%)

-$23,394,757 (-53.56%)

-$15,235,044 (-116.65%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$32,285,028 (173.78%)

$11,792,110 (1339.42%)

$819,224 (92.56%)

$425,443 (-11.62%)

Debt Current

$358,687 (-61.90%)

$941,542 (199.92%)

$313,933 (54.42%)

$203,292 (61.87%)

Debt Non-Current

$31,926,341 (194.24%)

$10,850,568 (2047.39%)

$505,291 (127.45%)

$222,151 (-37.56%)

Total Liabilities

$49,180,030 (67.95%)

$29,283,132 (51.61%)

$19,315,411 (209.32%)

$6,244,427 (56.66%)

Liabilities Current

$15,290,071 (11.06%)

$13,767,877 (7.51%)

$12,806,309 (112.65%)

$6,022,276 (70.13%)

Liabilities Non-Current

$33,889,959 (118.43%)

$15,515,255 (138.36%)

$6,509,102 (2830.03%)

$222,151 (-50.20%)

SMTI Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$86,672,425 (33.36%)

$64,989,842 (41.77%)

$45,842,845 (89.87%)

$24,143,919 (54.90%)

Cost of Revenue

$8,139,901 (3.66%)

$7,852,686 (23.45%)

$6,360,851 (175.22%)

$2,311,221 (42.97%)

Selling General & Administrative Expense

$76,559,863 (34.33%)

$56,994,753 (23.97%)

$45,976,328 (63.89%)

$28,053,176 (50.23%)

Research & Development Expense

$5,703,362 (38.01%)

$4,132,425 (22.73%)

$3,367,032 (502.65%)

$558,704 (1290.16%)

Operating Expenses

$87,186,449 (34.54%)

$64,802,204 (25.31%)

$51,714,428 (77.05%)

$29,208,855 (53.69%)

Interest Expense

$3,128,395 (557.53%)

$475,783 (67.09%)

$284,746 (39948.66%)

$711 (-93.83%)

Income Tax Expense

$0 (0%)

$0 (0%)

-$5,844,796 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$9,911,898 (-123.25%)

-$4,439,902 (45.13%)

-$8,092,328 (-1.23%)

-$7,993,795 (-79.83%)

Net Income to Non-Controlling Interests

-$247,351 (-80.94%)

-$136,705 (11.71%)

-$154,831 (-115.40%)

-$71,881 (18.97%)

Net Income

-$9,664,547 (-124.59%)

-$4,303,197 (45.79%)

-$7,937,497 (-0.20%)

-$7,921,914 (-81.84%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$9,664,547 (-124.59%)

-$4,303,197 (45.79%)

-$7,937,497 (-0.20%)

-$7,921,914 (-81.84%)

Weighted Average Shares

$8,484,224 (2.48%)

$8,278,949 (4.71%)

$7,906,794 (7.70%)

$7,341,580 (28.02%)

Weighted Average Shares Diluted

$8,484,224 (2.48%)

$8,278,949 (4.71%)

$7,906,794 (7.70%)

$7,341,580 (28.02%)

Earning Before Interest & Taxes (EBIT)

-$6,536,152 (-70.77%)

-$3,827,414 (71.64%)

-$13,497,547 (-70.40%)

-$7,921,203 (-82.31%)

Gross Profit

$78,532,524 (37.45%)

$57,137,156 (44.72%)

$39,481,994 (80.84%)

$21,832,698 (56.28%)

Operating Income

-$8,653,925 (-12.90%)

-$7,665,048 (37.34%)

-$12,232,434 (-65.84%)

-$7,376,157 (-46.51%)

SMTI Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$6,611,643 (35.23%)

-$10,207,346 (-190.67%)

-$3,511,630 (33.55%)

-$5,284,731 (-92.57%)

Net Cash Flow from Financing

$17,366,506 (80.13%)

$9,641,123 (1636.81%)

-$627,346 (-102.22%)

$28,296,732 (4446.90%)

Net Cash Flow from Operations

-$23,784 (99.27%)

-$3,245,556 (41.57%)

-$5,554,870 (-15.38%)

-$4,814,526 (-19.33%)

Net Cash Flow / Change in Cash & Cash Equivalents

$10,731,079 (381.52%)

-$3,811,779 (60.68%)

-$9,693,846 (-153.27%)

$18,197,475 (395.58%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

-$9,942,750 (-295.16%)

-$2,516,164 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$6,382,343 (0%)

$0 (0%)

-$250,000 (94.49%)

-$4,534,278 (-312.21%)

Capital Expenditure

-$205,848 (22.20%)

-$264,596 (-81.90%)

-$145,466 (15.36%)

-$171,867 (68.43%)

Issuance (Repayment) of Debt Securities

$17,566,711 (98.15%)

$8,865,546 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

-$200,205 (-125.81%)

$775,577 (290.40%)

-$407,346 (-101.43%)

$28,496,732 (72355.46%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$4,436,048 (28.85%)

$3,442,722 (27.38%)

$2,702,633 (1.26%)

$2,668,892 (90.24%)

Depreciation Amortization & Accretion

$5,470,521 (36.15%)

$4,017,998 (52.51%)

$2,634,586 (241.30%)

$771,930 (88.75%)

SMTI Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

90.60% (3.07%)

87.90% (2.09%)

86.10% (-4.76%)

90.40% (0.89%)

Profit Margin

-11.20% (-69.70%)

-6.60% (61.85%)

-17.30% (47.26%)

-32.80% (-17.56%)

EBITDA Margin

-1.20% (-500.00%)

0.30% (101.27%)

-23.70% (19.93%)

-29.60% (-17.00%)

Return on Average Equity (ROAE)

-23.50% (-135.00%)

-10.00% (51.92%)

-20.80% (11.11%)

-23.40% (66.90%)

Return on Average Assets (ROAA)

-12.00% (-87.50%)

-6.40% (58.97%)

-15.60% (25.00%)

-20.80% (53.36%)

Return on Sales (ROS)

-7.50% (-27.12%)

-5.90% (79.93%)

-29.40% (10.37%)

-32.80% (-17.56%)

Return on Invested Capital (ROIC)

-19.60% (27.14%)

-26.90% (87.01%)

-207.10% (-76.41%)

-117.40% (43.91%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-29.12 (63.15%)

-79.04 (-73.71%)

-45.5 (-66.30%)

-27.36 (58.33%)

Price to Sales Ratio (P/S)

3.25 (-37.93%)

5.24 (-33.28%)

7.85 (-12.65%)

8.98 (-51.06%)

Price to Book Ratio (P/B)

7.37 (-5.91%)

7.83 (-13.34%)

9.03 (22.73%)

7.36 (-85.59%)

Debt to Equity Ratio (D/E)

1.25 (91.12%)

0.65 (41.34%)

0.46 (126.47%)

0.2 (-68.52%)

Earnings Per Share (EPS)

-1.14 (-119.23%)

-0.52 (48.00%)

-1 (7.41%)

-1.08 (-42.11%)

Sales Per Share (SPS)

10.22 (30.14%)

7.85 (35.39%)

5.8 (76.28%)

3.29 (21.01%)

Free Cash Flow Per Share (FCFPS)

-0.03 (93.63%)

-0.42 (41.19%)

-0.72 (-6.19%)

-0.68 (14.91%)

Book Value Per Share (BVPS)

4.64 (-14.24%)

5.42 (2.36%)

5.29 (26.74%)

4.17 (289.00%)

Tangible Assets Book Value Per Share (TABVPS)

5.13 (67.43%)

3.06 (-6.65%)

3.28 (-23.99%)

4.31 (267.77%)

Enterprise Value Over EBIT (EV/EBIT)

-47 (49.46%)

-93 (-244.44%)

-27 (-3.85%)

-26 (63.89%)

Enterprise Value Over EBITDA (EV/EBITDA)

-287.01 (-115.34%)

1,870.85 (5616.47%)

-33.91 (-19.06%)

-28.48 (64.19%)

Asset Turnover

1.08 (11.23%)

0.97 (7.41%)

0.9 (42.36%)

0.64 (-60.19%)

Current Ratio

2.18 (57.83%)

1.38 (-14.29%)

1.61 (-60.60%)

4.09 (222.75%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$229,632 (93.46%)

-$3,510,152 (38.42%)

-$5,700,336 (-14.32%)

-$4,986,393 (-8.90%)

Enterprise Value (EV)

$305,852,364 (-14.22%)

$356,554,882 (-3.22%)

$368,401,106 (80.91%)

$203,638,322 (-34.95%)

Earnings Before Tax (EBT)

-$9,664,547 (-124.59%)

-$4,303,197 (68.78%)

-$13,782,293 (-73.98%)

-$7,921,914 (-81.84%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$1,065,631 (-659.14%)

$190,584 (101.75%)

-$10,862,961 (-51.94%)

-$7,149,273 (-81.64%)

Invested Capital

$44,600,097 (144.78%)

$18,220,324 (266.05%)

$4,977,545 (-32.91%)

$7,418,787 (130.78%)

Working Capital

$18,015,917 (243.95%)

$5,237,992 (-32.93%)

$7,810,200 (-57.98%)

$18,586,219 (1872.18%)

Tangible Asset Value

$43,483,435 (71.58%)

$25,343,307 (-2.24%)

$25,923,625 (-18.14%)

$31,668,461 (370.66%)

Market Capitalization

$290,206,545 (-17.30%)

$350,931,898 (-7.12%)

$377,819,670 (67.53%)

$225,526,900 (-28.19%)

Average Equity

$41,046,106 (-4.50%)

$42,980,690 (12.73%)

$38,128,788 (12.44%)

$33,909,227 (450.69%)

Average Assets

$80,233,253 (19.93%)

$66,897,839 (31.87%)

$50,731,051 (33.39%)

$38,031,758 (289.14%)

Invested Capital Average

$33,417,210 (134.95%)

$14,223,249 (118.27%)

$6,516,384 (-3.39%)

$6,745,023 (224.95%)

Shares

8,741,161 (2.37%)

8,538,489 (2.83%)

8,303,729 (8.80%)

7,632,044 (21.26%)